Transforming growth factor β-induced protein promotes severe vascular inflammatory responses

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 7, 2014, Pages 779-786

  Bae, Jong Sup ^a   Lee, Wonhwa ^a   Nam, Ju Ock ^b   Kim, Jung Eun ^b   Kim, Shin Woo ^a   Kim, In San ^a,c  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Cecal ligation and puncture; Endothelial dysfunction; Permeability; Sepsis; Transforming growth factor b induced protein

Indexed keywords

ALPHAVBETA5 INTEGRIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; F ACTIN; G ACTIN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADHESION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CECUM; CELL LYSATE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; GENOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LIGATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY CELL; SEPSIS; SEPTIC SHOCK; SHIVERING; THROMBOCYTE; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULITIS; WEAKNESS;

ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CECUM; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LEUKOCYTES; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERMEABILITY; RECEPTORS, VITRONECTIN; SEPSIS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 84897371722     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201311-2033OC     Document Type: Article

References (55)

1. Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011; 17:153-159.
2. Weis SM. Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 2008; 15:243-249.
3. Singer M. Biomarkers in sepsis. Curr Opin Pulm Med 2013; 19:305-309.
4. Bogatcheva NV, Verin AD The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 2008; 76:202-207.
5. Shapiro NI, Schuetz P, Yano K., Sorasaki M, Parikh SM, Jones A.E., Trzeciak S., Ngo L, Aird WC. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010; 14:R182.
6. Pierrakos C, Vincent JL Sepsis biomarkers: a review. Crit Care 2010; 14: R15.
7. Sheppard D. Modulation of acute lung injury by integrins. Proc Am Thorac Soc 2012; 9:126-129.
8. *. Crit Care Med 2013; 41: 546-553.
9. Ranieri VM, Thompson BT, Barie P.S., Dhainaut JF, Douglas IS, Finfer S, Gardlund B., Marshall JC, Rhodes A, Artigas A, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366: 2055-2064.
10. Skonier J, Neubauer M, Madisen L., Bennett K, Plowman GD, Purchio AF cDNA cloning and sequence analysis of beta Ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 1992; 11:511-522.
11. Skonier J, Bennett K, Rothwell V., Kosowski S, Plowman G, Wallace P., Edelhoff S, Disteche C, Neubauer M, Marquardt H, et al. Beta-Ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in-vitro and suppresses the growth of cho cells in nude-mice. DNA Cell Biol 1994; 13:571-584.
12. Kim JE, Kim EH, Han E.H., Park RW, Park IH, Jun SH, Kim J.C., Young MF, Kim IS. A TGF-beta-inducible cell adhesion molecule, beta Ig-h3, is downregulated in melorheostosis and involved in osteogenesis. J Cell Biochem 2000; 77:169-178.
13. Bae JS, Lee SH, Kim J.E., Choi JY, Park RW, Yong Park J, Park HS, Sohn Y.S., Lee DS, Bae Lee E, et al. Beta Ig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin. Biochem Biophys Res Commun 2002; 294:940-948.
14. Kim JE, Kim SJ, Jeong H.W., Lee BH, Choi JY, Park RW, Park J.Y., Kim IS. RGD peptides released from beta Ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis. Oncogene 2003; 22: 2045-2053.
15. Kim JE, Jeong HW, Nam J.O., Lee BH, Choi JY, Park RW, Park J.Y., Kim IS. Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein beta Ig-h3 that interact with the alphavbeta5 integrin. J Biol Chem 2002; 277: 46159-46165.
16. Nam JO, Kim JE, Jeong H.W., Lee SJ, Lee BH, Choi JY, Park R.W., Park JY, Kim IS. Identification of the alphavbeta3 integrin-interacting motif of beta Ig-h3 and its anti-angiogenic effect. J Biol Chem 2003; 278: 25902-25909.
17. Eliceiri BP, Puente XS, Hood J.D., Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA SRC-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 2002; 157:149-160.
18. Su G, Hodnett M, Wu N., Atakilit A, Kosinski C, Godzich M., Huang XZ, Kim JK, Frank JA, Matthay MA, et al. Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function. Am J Respir Cell Mol Biol 2007; 36:377-386.
19. Su G, Atakilit A, Li J.T., Wu N., Bhattacharya M, Zhu J, Shieh J.E., Li E., Chen R, Sun S, et al. Absence of integrin alphavbeta3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am J Respir Crit Care Med 2012; 185:58-66.
20. Kim HJ, Kim PK, Bae S.M., Son HN, Thoudam DS, Kim JE, Lee B.H., Park RW, Kim IS. Transforming growth factor-beta-induced protein (TGFBIp/beta Ig-h3) activates platelets and promotes thrombogenesis. Blood 2009; 114:5206-5215.
21. Kim HJ, Kim IS Transforming growth factor-beta-induced gene product, as a novel ligand of integrin alphambeta2, promotes monocytes adhesion, migration and chemotaxis. Int J Biochem Cell Biol 2008; 40:991-1004.
22. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005; 4:854-865.
23. Lee TY, Gotlieb AI Microfilaments and microtubules maintain endothelial integrity. Microsc Res Tech 2003; 60:115-127.
24. Orlova VV, Economopoulou M, Lupu F., Santoso S, Chavakis T. Junctional adhesion molecule-c regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 2006; 203:2703-2714.
25. Harlan JM, Winn RK Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med 2002; 30:S214-S219.
26. Frode TS, Ferreira SI, Medeiros YS Analysis of local and systemic inflammatory responses induced by polymicrobial peritonitis in mice. Mediators Inflamm 2001; 10:237-243.
27. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
28. Joyce DE, Nelson DR, Grinnell BW Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med 2004; 32:S280-S286.
29. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-3777.
30. Perman SM, Goyal M, Gaieski DF Initial emergency department diagnosis and management of adult patients with severe sepsis and septic shock. Scand J Trauma Resusc Emerg Med 2012; 20:41.
31. Ventetuolo CE, Levy MM Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008; 29:591-603.
32. Lee BH, Bae JS, Park R.W., Kim JE, Park JY, Kim IS Beta Ig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin. Exp Mol Med 2006; 38:153-161.
33. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-1032.
34. Chen XL, Nam JO, Jean C, Lawson C., Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I., Uryu S, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012; 22:146-157.
35. Six I, Kureishi Y, Luo Z., Walsh K. Akt signaling mediates VEGF/VPF vascular permeability in vivo. FEBS Lett 2002; 532:67-69.
36. Breslin JW, Pappas PJ, Cerveira J.J., Hobson RW II, Duran WN VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 2003; 284:H92-H100.
37. Birukova AA, Cokic I, Moldobaeva N., Birukov KG Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. Am J Respir Cell Mol Biol 2009; 40:99-107.
38. Treutiger CJ, Mullins GE, Johansson A.S., Rouhiainen A., Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H., Tracey KJ, Andersson J, et al. High mobility group 1 b-box mediates activation of human endothelium. J Intern Med 2003; 254:375-385.
39. Fiuza C, Bustin M, Talwar S., Tropea M, Gerstenberger E, Shelhamer J.H., Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003; 101:2652-2660.
40. Andersson U, Wang H, Palmblad K., Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R., Zhang M, Yang H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565-570.
41. Park JS, Arcaroli J, Yum H.K., Yang H., Wang H, Yang KY, Choe K.H., Strassheim D., Pitts TM, Tracey KJ, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003; 284:C870-C879.
42. Frenette PS, Wagner DD Adhesion molecules-part 1. N Engl J Med 1996; 334:1526-1529.
43. Walley KR, Lukacs NW, Standiford T.J., Strieter RM, Kunkel SL Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996; 64:4733-4738.
44. Downey JS, Han J. Cellular activation mechanisms in septic shock. Front Biosci 1998; 3:d468-d476.
45. Murata A, Toda H, Uda K., Hayashida H, Kato T, Nakagawa H., Yokoyama S, Morishita H, Yamakawa T, Hirose J, et al. Protective effect of recombinant neutrophil elastase inhibitor (r-020) on sepsis-induced organ injury in rat. Inflammation 1994; 18:337-347.
46. Hotchkiss RS, Karl IE The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
47. Warren HS. Strategies for the treatment of sepsis. N Engl J Med 1997; 336:952-953.
48. Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008; 26:711-715.
49. Schefold JC, Hasper D, Reinke P., Monneret G, Volk HD Consider delayed immunosuppression into the concept of sepsis. Crit Care Med 2008; 36:3118.
50. Adib-Conquy M., Cavaillon JM Compensatory anti-inflammatory response syndrome. Thromb Haemost 2009; 101:36-47.
51. Remick DG. Pathophysiology of sepsis. Am J Pathol 2007; 170: 1435-1444.
52. Hotchkiss RS, Coopersmith CM, McDunn J.E., Ferguson TA The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009; 15: 496-497.
53. Kollef KE, Schramm GE, Wills A.R., Reichley RM, Micek ST, Kollef MH Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008; 134:281-287.
54. Monneret G, Venet F, Pachot A., Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008; 14:64-78.
55. Levy MM, Dellinger RP, Townsend S.R., Linde-Zwirble WT, Marshall JC, Bion J, Schorr C., Artigas A, Ramsay G, Beale R, et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36:222-231.